Artificial Tears — Class II drug recall D-0920-2023
Ongoing recall by Global Pharma Healthcare Private Limited, reported 2023-07-19, distributed nationwide. CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manuf
| Recall number | D-0920-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Global Pharma Healthcare Private Limited, Chennai, N/A, India |
| Recall initiated | 2023-01-30 |
| Classified | 2023-07-14 |
| Reported by FDA | 2023-07-19 |
| Distributed | Nationwide (US) |
| Quantity | 400,008 bottles |
| Reason classes | cgmp |
| NDC | 79503-0101-15 |
| Lot numbers | NOV-2023, PCMH009, PCMH010, PCMH011, PCMH012, PCMH013, PCMH014, PCMH015, PCMH016, PCMI001, PCMI002, PCMI003, PCMI004, PCMI006 |
Product
Artificial Tears (Carboxymethylcellulose Sodium) Lubricant Eye Drops, 10 MG in 1 ml, 1/2 fl oz (15 ml) bottle, Distributed by. EzriCare, LLC, Lakewood, NJ, NDC 79503-0101-15.
Reason for recall
CGMP Deviations: All other lots of eye drops are being recalled due to CGMP Deviations because they were manufactured in the same facility under the same conditions as the lots found to be contaminated.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0920-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.